PRP3: SPECIFIC IMMUNOTROPIC THERAPY — ASPECTS OF COST-EFFECTIVENESS

Autor:	P Bogdanovskiy, E Prosekova, V Dercach, B Geltzer
Jazyk:	angličtina
Předmět:	Risk analysis (engineering) Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health Medicine business
Zdroj:	Value in Health. (6):461
ISSN:	1098-3015
DOI:	10.1016/S1098-3015(11)71636-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01395984b49efe2ba3ed8644327a352 Zobrazit plný text záznamu